Chlamydia Trachomatis Antikörper

Produktnummer ABIN125948

Der Maus Monoklonal Anti-Chlamydia Trachomatis-Antikörper wurde für IF und IHC (fro) validiert. Er ist geeignet, Chlamydia Trachomatis in Proben von Chlamydia trachomatis zu detektieren.

Kurzübersicht für Chlamydia Trachomatis Antikörper (ABIN125948)

Target: Chlamydia Trachomatis

Reaktivität: Chlamydia trachomatis

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Chlamydia Trachomatis Antikörper ist unkonjugiert

Applikation: Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro))

Klon: 502

Produktdetails anti-Chlamydia Trachomatis Antikörper

Aufreinigung: Protein A affinity chromatography

Immunogen: Chlamydia antigen

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Immunofluorescence microscopy of cell culture: 1: 10. Immunohistochemistry on frozen section.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Rekonstitution: Restore with 1 mL dist. water

Buffer: PBS, pH 7.4 containing 0.5 % BSA and 0.09 % NaN3

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: This product is photosensitive and should be protected from light

Lagerung: 4 °C

Informationen zur Lagerung: Prior to and following reconstitution store the antibody undiluted at 2-8 °C. DO NOT FREEZE!

Details zu Chlamydia Trachomatis

Target: Chlamydia Trachomatis

Substanzklasse: Bacteria

Hintergrund: Chlamydia trachomatis is an intracellular organism. Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men. Chlamydial infections are believed to be one of the most common of all STDs. It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year. Thus, there are many undiagnosed cases of chlamydia in the community. It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5 % to 10 %. Chlamydia is one of the leading causes of blindness in underdeveloped countries.